UW19029
OPEN TO ACCRUAL
P2- 5FU, oxaliplatin, nal-IRI & immunotherapy (+ trastuzumab for HER2+) for adv esophageal & gastric
EA2234
OPEN TO ACCRUAL
Randomized Ph2/3 Systemic Tx +/-Intraperitoneal Paclitaxel in Gastric Carcinomatosis STOPGAP II
S2303
OPEN TO ACCRUAL
Adding Nivolumab to Usual Treatment for People with Advanced Stomach or Esophageal Cancer